by Desiree Cobb-Olori | Jun 5, 2025
A powerful tool for studying the effects of compounds on neuronal circuity. In vivo electrophysiology in the CNS allows for monitoring of single neuron-level activity or local field potentials in live subjects. PsychoGenics offers in vivo electrophysiological...
by Desiree Cobb-Olori | May 23, 2025
In recognition of Huntington’s Disease (HD) Awareness Month, PsychoGenics is proud to support your HD research needs. With decades of experience in HD research, we offer three, fully characterized, mouse models of HD for assessing potential therapeutics: the zQ175...
by Desiree Cobb-Olori | Mar 31, 2025
Rett Syndrome is a genetic neurological disorder caused by X-linked Mecp2 gene mutations. Males are more strongly affected and usually die before birth or early in life. Rett Syndrome symptom onset is 6-18 months of age with impairments including: seizures, severe...
by Desiree Cobb-Olori | Mar 25, 2025
Alzheimer’s Disease (AD) is an increasingly prevalent neurodegenerative disorder that is typically recognized for the progressive cognitive dysfunction it induces. However, agitation, a term covering symptoms of restlessness, irritability, and verbal or physical...
by Desiree Cobb-Olori | Feb 19, 2025
Huntington’s Disease (HD) is an autosomal dominant neurodegenerative disease caused by a high number of trinucleotide CAG repeats in the Huntingtin (Htt) gene. HD is classically associated with psychomotor symptoms including dyskinesia and dystonia,...
